Moffitt Cancer Center

Black, Hispanic and white individuals treated with idecabtagene vicleucel for relapsed or refractory multiple myeloma experienced similar PFS and OS, according to study results published in Blood Advances.

Better oral health appeared associated with higher survival rates among individuals diagnosed with head and neck cancer, results published in Journal of the National Cancer Institute showed.

Women diagnosed and treated for breast cancer experienced greater increases in biological aging than women who remained breast cancer-free, according to data published in Journal of the National Cancer Institute.

Magnetic resonance-guided daily adaptive stereotactic body radiotherapy appeared associated with a reduction in acute toxicity compared with a more common technique for men with prostate cancer, according to data published in Cancer.

An international research collaboration has contributed new insights into how the gut microbiome contributes to the effectiveness of immunotherapy for cancer.

Telemedicine garnered higher satisfaction ratings than in-person visits among patients with cancer in terms of access and care provider concern, according to a study published in Journal of the National Comprehensive Cancer Network.

More than half of ED visits between 2012 and 2019 among adults with cancer potentially could have been prevented, according to study results published in JAMA Network Open.

Although immunotherapies have been a game-changer in cancer treatment, they do not work for all patients.

Pure essential oils can reduce incidence of chemotherapy-induced nausea and vomiting among individuals who undergo bone marrow transplant, according to study results.

Brexucabtagene autoleucel continued to confer a greater than 70% complete remission rate among adults with relapsed or refractory B-cell acute lymphoblastic leukemia, results from the latest analysis of a pivotal phase 2 study showed.